| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8e49a2b5f6d0ba32839687472b3a437 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C31-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C31-20 |
| filingDate |
1986-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1986-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78021de2be967dfe4ff11d0fc438b42e |
| publicationDate |
1986-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4633025-A |
| titleOfInvention |
Method for preparing (+)R-2-methyl-hexane-1,2-diol |
| abstract |
A method for preparing important stereospecific intermediates in the synthesis of prostaglandin analogs is disclosed. Said intermediates are (+)R-2-methyl-hexane-1,2-diol and (-)S-2-methyl-hexane-1,2-diol and are prepared via an asymmetric halolactonization reaction utilizing L-proline and D-proline, respectively as the chiral agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4922032-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056935-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002052410-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002042377-A1 |
| priorityDate |
1985-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |